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Abstract: Ebola hemorrhagic fever (EHF) is a severe, often-fatal, zoonotic viral disease in humans and
nonhuman primates (monkeys, gorillas and chimpanzees) that has appeared sporadically since its initial
recognition in 1976.Now the disease is emerging that cases are being reported in different regions of the world.
The virus is one of two members of a family of RNA viruses called the Filoviridae. There are five identified
subtypes  of  Ebola  virus.  Four  of  the  five  have  caused  disease in humans: Ebola-Zaire, Ebola-Sudan,
Ebola-Ivory Coast and Ebola-Bundibugyo. The fifth, Ebola-Reston, has caused disease in non-human primates,
but not in humans. The disease causes hemorrhagic fever with high mortality rates. Filovirus epidemics have
originated from Africa and now spreading to other continents. There is no reported case of the disease in
Ethiopia. The virus is classified among the highest priority as bioterrorism agent. Contact with infected people
or animal, secretions and sexual intercourse are the major ways of transmission. Symptoms characterizing EHF
are unspecific in the first few days of the infection, making the virus even more dangerous. Infection is marked
by initial signs of fever, fatigue, exhaustion, muscle aches and dizziness. As the disease progress bleeding
under the skin, in internal organs and from the eyes, ears and mouth are seen. Patients with severe progressions
of the disease express symptoms of shock, delirium, coma, seizures and nervous system malfunction. The Ebola
virus is diagnosed by specific antigens detected in blood specimens, isolation of virus in cell cultures, or
detection of IgM and IgG antibodies. ELISA tests are often used to diagnose the viruses. There is no effective
treatment for Ebola. Infected patients are treated with general supportive therapy that replenishes intravenous
fluids, maintains blood pressure and other bodily functions. There is no vaccine for the disease. Prevention and
control is mainly based on appropriate precautions to break ways of transmission.
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INTRODUCTION Out of the emerging pathogens, 132 (75%) are zoonotic
As defined by the World Health Organization, be associated with emerging diseases than non-zoonotic
zoonoses are “those diseases and infections which are pathogens [2].
naturally transmitted between vertebrate animals and man, Zoonotic diseases represent one of the leading
with or without an arthropod intermediate”. Outbreaks of causes of illness and death from infectious disease.
zoonotic diseases emerge either by apparently new agents Worldwide, zoonotic diseases have a negative impact on
or by known microorganisms that appear in areas or commerce, travel and economies. In most developing
species in which the disease was previously unknown. countries, zoonotic diseases are of major public health
New animal diseases with an unknown host spectrum are significance and contribute to an already overburdened
also included in this definition [1]. public health system. In industrialized nations, zoonotic
There are about1415 species of infectious organism diseases are of particular concern for at-risk groups such
known to be pathogenic to humans. Out of these, 868 as the elderly, children, pregnant women and immuno-
(61%) are zoonotic, that is, they can be transmitted compromised individuals. The potential use of zoonotic
between humans and animals and 175pathogenic species pathogens as bioterrorism agents should be considered
are associated with diseases considered to be 'emerging'. as well [1, 3].
and overall, zoonotic pathogens are twice more likely to
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Table 1: Viruses in the family Filoviridae.
Genus or subgenus Type species Assumed source (s) of  Infection Geographical Occurrence
Genus Marburg virus Marburg virus Vervet monkeys (Cercopithecus aethiops) East Africa
Genus Ebola virus Ebola virus Chimpanzees, Gorillas Equatorial Africa
Ebola virus Zaire Chimpanzees (Pan troglodytes) Republic of Congo,Gabon
Ebola virus Maridi Unknown Sudan,Uganda
Ebola virus Ivory cost Chimpanzees West Africa
Subgenus Reston virus Reston virus Java cynomolgus monkeys (Macaca fascicularis) Southern Asia
Source: Hartmut et al. [10]
The epidemiologic characteristics of the coming viral hemorrhagic fever include arena viruses, filoviruses,
decade will be a continuous foreground reprioritizing of bunya viruses and flaviviruses. All virions classified as
diseases because of changes in the frequency and hemorrhagic are enveloped (covered) RNA viruses,
relative1 importance of various inconsistent risk factors whose survivals dependent on an animal reservoir [6].
and their responses to control. As certain factors become Four varieties of Ebola virus are known to exist: Ebola
more common, related diseases will occur more frequently. Zaire (EBOZ), Ebola Sudan (EBOS), Ebola Reston (EBOR)
Similarly, changes reducing other factors will in turn result and Ebola Ivory Coast. Ebola-Reston has caused disease
in a lower incidence of other diseases and perhaps a in nonhuman primates, but not in humans [7]. Ebola virus,
relatively greater dependence on previously minor factors. an elongated filamentous RNA virus can be as long as
The importance of viral evolutionary mechanisms and the 0.70nm or longer. The virus was discovered in 1976 and
emergence of new virulence factors encoded by named after the Ebola River in Zaire close to the location
bacteriophages, plasmids and transposons significantly of the first cases [8].
affecting disease incidence is a matter of heated academic Viruses within this family are characterized by
argument [4]. Scenarios that have or will increase the enveloped, pleomorphic (filamentous) virions and a
incidence of new zoonoses are international travel, genome of single stranded molecule of negative-sense
increasing proportions and numbers of human and RNA. There are two major groups of filoviruses. Ebola
companion animal populations, water contamination, and Marburg are related viruses. Viruses within these
regional, transcontinental and international food groups cause severe fatal disease of humans that are
industries, emerging specialist farms with exotic species characterized as “hemorrhagic fever” because of the
and social engineering and human behavior [4,5]. spectacular diseases they cause in affected humans.
EHF is an emerging zoonotic viral disease caused by These viruses infect primates and can be adapted to
the virus called Ebola virus grouped under the family laboratory animals [9].
Filoviridae. In humans, persons with illness caused by Hemorrhagic fever viruses belong to different virus
Filovirus infection usually have influenza likes symptoms, families and are extremely pathogenic although not high
with subsequent disseminated intravascular contagious. Ebola virus is best known as an agent in
coagulopathy (DIC) and often generalized bleeding from hospital-associated disease outbreaks in African
body orifices. Pathologically, there is early and sustained hospitals [10]. The virions of the family Filoviridae are
infection of the mononuclear phagocyte system. There is threadlike and very long(filo means threadlike).The virus
no cure or vaccine and treatment is symptomatic. The is stable at room temperature and can resist desiccation;
infections are transmitted by direct contact and all body inactivated at 60 C for 30 minutes; infectivity greatly
fluids contain large amounts of the rapidly replicating reduced or destroyed by UV light and gamma irradiation,
virus. Nonhuman primates have introduced the virus into lipid solvents, b-propiolactone, formaldehyde, sodium
human populations, but the animals appear to be hypochlorite and phenolic disinfectants [11]. Both
amplifiers rather than reservoirs of the disease [5]. Marburg and Ebola viruses have several serotypes and all
Therefore, the objectives of this seminar paper are; to look are African viruses, with the exception of Reston Ebola
at the general overview of the disease Ebola Hemorrhagic virus, which was traced to the Philippines. The natural
Fever and to assess the emergence and re-emergence of histories, reservoirs and epidemiology’s of the viruses are
the disease and its zoonotic importance. largely unknown [12].
Etiology: Ebola belongs to a family of viruses entitled Genome of the Virus: Filoviridae have non-segmented
Filoviridae and is commonly classified under viruses single strand genome which are closely related to the
causing viral hemorrhagic fever. The known causes of genus  Pneumovirus, Marburg virus and Ebola virus each
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constitute a separate genus based on difference in their
genome organization. Antigenically distant subtype of
Ebola virus is Reston virus [.Samples from Sudan and
Zaire have revealed the presence of a new virus,
morphologically similar to Marburg virus but antigenically
different [13].
Viruses in the family Filoviridae are
mononegaviruses, which means they have an
unsegmented genome with negative polarity. Based on
the differences in the genetic make-up, there are two
genera in this family: Marburg virus and Ebola virus.
Marburg virus has seven gene products. Ebola virus has
an additional soluble glycoprotein (sGP) which may be
connected with the regulation of its pathogenicity. The 3`
and 5` ends of the RNA are conserved and reveal a high
degree of complementarity. Both viruses have a
nucleocapsid protein gene at the 3` end of the genomic
RNA [10]. Filovirus virions are characterized by having
one molecule of single stranded; negative sense RNA, as
well as their unique "U" shaped structures. The capsomer
covered nucleocapsid is helicoid in shape [14].
Emergence of the Disease: An emerging viral disease is
one that is newly recognized or newly evolved or that has
occurred previously but shows an increase incidence or
expansion in geographical, host or vector range. Constant
changes in demographic, ecological and anthropogenic
factors ensure that new and recurring diseases will
continue to emerge, but virological and host determinants
also contribute to the emergence of some viral diseases
and the emergence of new diseases in particular [15].
The most important factors for emerging zoonotic
diseases are the transportation of humans and animals to
new areas, increased contact between animals and
humans, changes in the environment and husbandry
practices, a larger immuno-compromised population,
increased recognition of diseases as zoonotic in origin
and the discovery of new organisms not previously
recognized [5].
There are multiple explanations for the emergence
and reemergence of infectious diseases: Climate change,
injudicious and widespread use of antimicrobials,
bioterrorism (‘weaponization’ of pathogens), mobile
human populations, environmental modification, human
population encroachment on wilderness (vector
populations, concentration of human populations,
dispersal of vectors (and pathogens) through trade,
transport, migration and immuno-compromised
populations [16].
Table 2: Reports of Ebola Hemorrhagic Fever from 1976-2000
Year Location Total cases reported Mortality (%)
1976 Zaire 318 88
1995 Zaire 315 81
1994 Ivory cost 2 0
1994 Gabon 44 64
1996 Gabon 37 57
1996 Gabon 60 75
1976 Maridi 284 53
1979 Maridi 34 65
2000 Uganda 329 32.5
2001 South Sudan 20 25
2003 Uganda 425 53
2007 DRC 249 73.5
2007 Uganda 49 28.6
2008 Uganda 149 24.8
2012 Uganda 24 70.8
2014 Guinea 236 70
2014 Liberia 22 63.6
Total - 2597 54.4
Source: CDC and WHO report postings 
Marburg and Ebola viruses are emerging viruses as
they have newly appeared or are rapidly expanding their
range with a corresponding increase in cases of disease.
In general, there is no way to predict when or where the
next important new zoonotic pathogen will emerge or what
its ultimate importance might be. A pathogen might
emerge as the cause of a geographically limited curiosity,
intermittent disease outbreaks, or a new epidemic [3].
Epidemiology: Ebola Hemorrhagic Fever typically appears
in sporadic outbreaks, usually spread within a health-care
setting (a situation known as amplification). It is likely that
sporadic, isolated cases occur as well, but go
unrecognized [17].
The disease burden of Ebola in comparison to
HIV/Malaria/TB is small.Total number of identified cases
are less than 3000. There is increasing frequency of
outbreaks in sub-Saharan Africa of which significant
ongoing outbreaks in wild (endangered) non-human
primate species (chimpanzees) [16].
The exact origin, locations and natural habitat (known
as the "natural reservoir") of Ebola virus remain unknown.
However, on the basis of available evidence and the
nature of similar viruses, researchers believe that the virus
is zoonotic (animal borne) with four of the five subtypes
occurring in an animal host native to Africa. A similar
host, most likely in the Philippines, is probably associated
with the Ebola-Reston subtype, which was isolated from
infected cynomolgus monkeys that were imported to the
United States and Italy from the Philippines. The virus is
not known to be native to other continents, such as North
America [17].
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Distribution: The known geographic range of primary In the 1995 outbreak in Kikwit, DRC, infection rates
Filovirus infection is in tropical Africa with the exception
of Reston Ebola virus, which occurs in Philippines. The
fact that the Ebola virus subtypes that have caused
human disease episodes have been different from each
other makes it clear that a common source transmission
chain extending across sub-Saharan Africa is not the case
rather distinct virus subtypes from each site of human
disease episodes have been responsible [15]. 
Confirmed cases of Ebola HF have been reported in
the Democratic Republic of the Congo, Gabon, Sudan, the
Ivory Coast, Uganda and the Republic of the Congo. EHF
typically appears in sporadic outbreaks, usually spread
within a health-care setting. It is likely that sporadic,
isolated cases occur as well, but go unrecognized [17].
Risk  Factors:  In  a  study  among  the  post  primary
case-1patients, the most important risk factor was direct
repeated contact with a sick person’s body fluids, as
occurs during the provision of care. As expected, the risk
was higher when the exposure took place during the late
stage of the disease at home. The risk was reduced when
the patient stayed in hospitals, probably because of the
use of gloves, even before strict barrier nursing was
implemented. However, having washed the clothes of a
sick person and having participated in the ritual hand
washing during the funeral ceremony were significant risk
factors [18].
There is a specific risk for healthcare workers,
especially if involved in caring for Ebola hemorrhagic
fever patients (e.g. volunteers). However, the level of
precaution taken in such settings should effectively
prevent the transmission of the disease. There is a risk of
transmission through unprotected sexual contact with a
patient that has recently recovered from the disease [19].
Women are mostly affected by disease because they
process the bush-meat for conservation and meal
preparation. They also mourn the dead with tendency to
physical contact with corpse. Families of those who have
been infected are stigmatized and smeared even long after
the epidemic outbreak has been declared over [20].
Individuals considered at risk for Ebola hemorrhagic
fever include persons with a travel history to sub-Saharan
Africa, persons who have recently cared for infected
patients and animal workers who have worked with
primates infected with African-derived Ebola subtypes. In
2011, Uganda experienced a reemergence of the disease
[21].
were significantly lower in children than in adults. During
this outbreak, only 27 (8.6%) of the 315 patients
diagnosed with Ebola virus infection were aged 17 years
or younger. This apparent sparing of children occurs even
though 50% of the population of the DRC is younger than
16 years. Although definitive evidence is lacking,
epidemiologic evidence suggests that children are less
likely to come into direct contact with ill patients than
adults are [17].
Ebola virus infection has no sexual predilection, but
men and women differ with respect to the manner in which
direct exposure occurs. Men, by the nature of their work
exposure in forest and savanna regions, may be at
increased risk of acquiring a primary infection from
gathering “bush meat” (primate carcasses) for food, as
well as an unknown vector or vectors. Evidence from
Africa and the Philippines is compatible with bats being
a principal vector of Ebola virus. Because women provide
much of the direct care for ill family members and are
involved in the preparation of the bodies of the deceased,
they may be at increased risk of acquiring Ebola virus
infection through their participation in these activities.
However, men and women who are medical healthcare
providers seem to share a high and equal risk of infection
[5].
Because most cases of Ebola virus infection have
occurred in sub-Saharan Africa, most patients have been
black. However, no evidence exists for a specific racial
predilection. During outbreaks of EHF, those at highest
risk include health care workers and the family and friends
of an infected individual. Health care workers in Africa
should consult the Infection Control for Viral Hemorrhagic
Fevers [6].
Source of Infection: The reservoir of the virus in nature is
unknown. In studies conducted in Sudan and DRC the
virus couldn’t be isolated and antibodies couldn’t be
detected in more than 1,000 captured animals most of them
being mammals [14].Nonhuman primates have introduced
the virus into human populations, but the animals appear
to be amplifiers rather than reservoirs of the disease.
Recent study suggests bats are reservoir for Ebola
virus in Bangladesh. Experimentally infected fruit bats
shown to replicate Ebolavirus without developing overt
disease. Virus-specific antibody and genome RNA
detected predominantly in Egyptian fruit bats (Rousettus
aegyptiacus) in Gabon, Durba DRC, Kitaka Uganda and
Python Cave, Uganda. Multiple virus isolates from Kitaka
and Python caves [22].
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Mortality: The mortality rate has been very high up to equipment, especially needles and syringes, resulted in
80% with Marburg virus, 60%with Sudan Ebola virus and rapid nosocomial spread of infection. Only after adequate
90% with Zaire Ebola virus infections. Convalescence is barrier protection and alteration in burial rituals were
slow and marked by prostration, weight loss and often by implemented was the outbreak contained [17].
amnesia for the period of acute illness. Death is usually Because the natural reservoir of Ebola viruses has
attributed to hypovolemic shock, sometimes accompanied not yet been proven, the manner in which the virus first
by disseminated hemorrhage. Human infections with appears in a human at the start of an outbreak is
Reston Ebola virus have so far been subclinical [15]. unknown. However, researchers have hypothesized that
Transmission: African-derived filovirus infections are infected animal. When an infection does occur in humans,
characterized by transmission from an unknown host there are several ways in which the virus can be
(possibly bats) to humans or nonhuman primates, transmitted to others. These include, direct contact with
presumably via direct contact with body fluids such as the blood or secretions of an infected person, exposure to
saliva or blood or other infected tissues. Evidence in objects (such as needles) that have been contaminated
nonhuman primates indicates that Sudan Ebola virus and with infected secretions [8].
Zaire Ebola virus may be transmitted by contact with The viruses that cause EHF are often spread through
mucous membranes, conjunctiva, pharyngeal and families and friends because they come in close contact
gastrointestinal (GI) surfaces; through small breaks in the with infectious secretions when caring for ill persons.
skin; and, at least experimentally, by aerosol [23]. During outbreaks of Ebola HF, the disease can spread
Dogs have been shown to acquire asymptomatic quickly within health care settings (such as a clinic or
Ebola    virus  infections,  possibly  by  contact  with hospital). Exposure to Ebola viruses can occur in health
virus-laden droplets of urine, feces, or blood of unknown care settings where hospital staffs are not wearing
hosts. Of epidemiologic significance was the observation appropriate protective equipment, such as masks, gowns
that sero-prevalence rates in dogs rose in a linear fashion and gloves. Proper cleaning and disposal of instruments,
as  sampling  approached  areas  of  human  cases, such as needles and syringes, is also important. If
reaching as high as 31.8%. Thus, an increase in canine instruments are not disposable, they must be sterilized
sero-prevalence may serve as an indicator of increasing before being used again. Without adequate sterilization of
Ebola virus circulation in primary vectors within specific the instruments, virus transmission can continue and
geographical areas [15]. amplify an outbreak [6].
Human infection with African-derived strains has Unlike Asian-derived Ebola virus (Reston Ebola
often occurred in caregivers (either family or medical) and virus, traced to a Philippine supplier of primates), African-
in family members who have prepared dead relatives for derived species appear to be spread more often by direct
burial. Late stages of Ebola virus disease are associated contact than via the respiratory route. However, the
with the presence of large numbers of virions in body Reston species has repeatedly been demonstrated to
fluids, tissues and, especially, skin. Individuals who are spread among nonhuman primates and possibly from
exposed to patients infected with Ebola without proper primates to humans via the respiratory route. Fortunately,
barrier protection are at high risk of becoming infected although the Reston species has been documented to be
[10]. capable of infecting in humans, it does not appear to be
A report from the DRC identified Ebola virus RNA in pathogenic to humans [15].
100% of oral secretions from patients who had the viral
RNA in their serum. Both serum and oral secretions were Pathogenesis: Pathogenesis is the entry, primary
tested  with  reverse-transcriptase  polymerase chain replication, spread to target organs and establishment of
reaction (RT-PCR) assay. Thus, oral secretions may be infection in the target organs whereas virulence can be
capable of transmitting Ebola virus [18]. defined as the degree of pathogenicity of an infectious
The first recorded outbreak occurred in 1976, in agent, indicated by case fatality rates and/or its ability to
Yambuku, DRC, where 316 patients were infected. In the invade and damage tissues of the host. The process by
largest recorded urban outbreak to date (DRC, 1995; 318 which a pathogen replicates itself in the human host
cases), admission to a hospital greatly amplified the depends on cell-specific and organ-specific receptors, cell
frequency of transmission. The lack of proper barrier and tissue injury and host immunity and other defense
protection and the use and reuse of contaminated medical factors [1].
the first patient becomes infected through contact with an
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Although poorly understood, it has been proposed Although a full understanding of Ebola virus disease
that several mechanisms may be responsible for the must await further investigations, part of the
pathophysiologic changes that make Marburg and Ebola pathogenesis has been elucidated. Clinical infection in
infections so devastating. In several studies, necrosis of human and nonhuman primates is associated with rapid
the parenchymal cells of the liver was correlated with the and extensive viral replication in all tissues. Viral
presence of large numbers of Ebola virions intarget cells. replication is accompanied by widespread and severe
The high AST: ALT ratio combine with normal bilirubin focal necrosis. The most severe necrosis occurs in the
also suggest the importance of extra-hepatic targets of liver and this is associated with the formation of
infection. Endothelial cell infection and in-situ deposition Councilman-like bodies similar to those seen in yellow
of fibrin point to DIC. Increased  endothelial  permeability fever. In fatal infections, the host’s tissues and blood
leading to extensive visceral effusions, pulmonary contain large numbers of Ebola virions and the tissues
interstitial edema and renal tubular dis-function are and body fluids are highly infectious [8].
important components of shock seen in Ebola infected While disseminated intravascular coagulation (DIC)
patients. In infected primates, apart from the severe is often viewed to be a prominent manifestation of Ebola
thrombocytopenia, the presence of agonists such as virus infection in primates, the presence of DIC in human
adenosine diphosphate renders the remaining platelets filoviral infections has been a controversial topic; cultural
incapable of agglutination. After infection, human and mores and logistical problems have hampered systematic
nonhuman primates experience an early period of rapid studies [25].
viral multiplication that, in lethal cases, is associated with
an ineffective immunologic response [8]. Ebola in Humans: When the disease does manifest,
Acute infection of humans with Ebola, one principal clinical symptoms range from mild illness to swift and fatal
etiologic agent of hemorrhagic fevers, often results in a conditions. The IP lasts about a week and onset is sudden
paradoxical pattern of immune responses: early infection, with fever and headache. A large proportion of patients
characterized by an outpouring of inflammatory mediators experience thoracic pain, diarrhea, vomiting, dry and sore
such as TNF-á, IL-10 and IL-6, late stage infections, which throat and an erythematous maculo-papular eruption on
are associated with poor immune responses. The the trunk, which rapidly spreads to other parts of the
mechanisms underlying these diverse outcomes are body and tends to become confluent. The erythema may
poorly understood. In particular, the role played by cells not be noticed on dark-skinned individuals.
of the innate immune system, such as dendritic cells (DC), Desquamation ensues after 3 or 4 days [14].
is not known [6]. Four or five days after onset of the disease, patients
Ebola viruses infect human monocyte-derived DC develop extreme lethargy and changes in their mental
and impair their function. Monocyte-derived DC exposed state, gravely ill patients exhibit restlessness and
to either virus fail to secrete pro-inflammatory cytokines, confusion and then lapse in to a deep coma before they
do not up-regulate co-stimulatory molecules and are poor die [26].
stimulators of T cells. Ebola virus target DC to impair The  high  fever  continues  for  a   week,     after
adaptive immunity [24]. which it gradually subsides. Data from past cases show
Data from in vitro experiments and animal models that more than 90% of the patients who died, as well as
suggest that Ebola infect macrophages and endothelial 48% of those who recovered  had  hemorrhagic
cells early in infection. Infection of these cell types, two symptoms. Among the latter, melena was the most
principal players of the innate immune system, are common and hematemesis, epistaxis and bleeding in other
believed to act as critical triggers for the rapid and organs and tissues were also frequently observed.
uncontrolled secretion of inflammatory mediators, Convalescence was slow and in some cases took up to
However, despite the systemic release of inflammatory two months. The hemorrhagic manifestations are less
mediators that occurs following infection with Ebola, severe at the end of the outbreak than they are at the
severe orfatal diseases are often associated with a beginning [27].Pregnant women usually abort their fetus
generalized suppression of adaptive immunity, as and have copious hemorrhaging. There are no known
evidenced by the low specific antibody and poor cellular cases of human disease caused by the Reston strain of
immunity [17]. the virus [3].
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Ebola virus outbreaks provide dreadful publicity for
Tourism and Investment. Bush-meat is an essential
component of Congolese eating habits, particularly in
areas with highest risks for Ebola virus outbreaks. Hence,
during outbreaks Government and international
organization must provide for all the food which is
imported from outside the area. However, inhabitants are
not interested in alternatives to readily available
traditional foods such as Gorilla or Chimpanzee meat as
part of tradition and social maturation. Some traditional
customs incite young men to hunt down apes and
thereafter consume their heart to gain bravery and
demonstrate hunting skills. During outbreaks women are
not allowed go to the fields to maintain crops and fish
[20].
Ebola in Animals: Non-human primates are in general
highly susceptible to Filovirus infections. Large outbreaks
of lethal Ebola virus infection have been reported in wild
populations of gorillas (Gorilla gorilla) and chimpanzees
(genus pan). In rhesus monkeys (Macaca mulatta),
cynomolgus monkeys (Macaca fascicularis), African
green monkeys (Cercopithecus aethiops) and baboons
(Papio species) inoculated with Marburg virus or Zaire
Ebola virus the incubation period of 4-6 days is followed
by an abrupt onset of clinical disease marked by
petechiae, ecchymosis, hemorrhagic pharyngitis,
hematemesis, melena and prostration. Infection nearly
always ends in death. The pathogenesis of filovirus
infections is apparently similar in those non-human
primates and humans. Mice and guinea pigs are not
highly susceptible to field isolates of filoviruses but
rodent adapted strains of the viruses do induce uniformly
lethal disease and have been utilized for testing vaccines
and therapeutic agents [15].
When inoculated experimentally in various monkey
species, the Ebola virus causes severe disease
characterized at first by fever and depression followed by
diarrhea, petechiae, languor, shock and finally death
[28].In the Cynomolgus macaques imported in to Italy and
the United States from the Philippines, the infection
caused by the Reston strain of the virus produced disease
and a high case fatality rate. Antibodies have also been
found in other old world primates [21]. The Sudan and
Reston subtypes of Ebola virus are least pathogenic for
primates and guinea pigs, killing only a fraction of animals
inoculated with un-passaged virus. Serial passage
increases the virulence of these viruses for these hosts
[29].
Table 3: Laboratory tests used in diagnosis with respective time of infection
Timeline of Infection Diagnostic Tests Available




Later in disease courseor after recovery -IgM and IgG antibodies.
Retrospectively in diseased patients -Immuno-histochemistry testing
-PCR
-Virus isolation
Source: CDC Ebola Hemorrhagic Fever factsheet, 2002
Diagnosis: The ability of diagnosing diseases both old
and emerging, in humans and in animals often is
overlooked. Basic anatomic pathology involves analyzing
tissues from dead specimens, making observations,
interpreting those findings and following up with
histopathology studies of samples under a microscope. In
recent years, the advent of molecular pathology has
heightened the power of diagnostic pathology. Using
such tools as immunohistochemistry, in situ hybridization
and polymerase chain reaction (PCR) assays, pathologists
now can identify the etiology, or cause of death, faster
than ever before and, in many cases, where it would
otherwise have been impossible. However, current
disease surveillance systems, for human diseases and
zoonoses alike, fail to make adequate use of diagnostic
pathology [1].
Diagnosing EHF in an individual who has been
infected only a few days is difficult because early
symptoms, such as red eyes and a skin rash, are
nonspecific to the virus and are seen in other patients
with diseases that occur much more frequently. Antigen-
capture enzyme-linked immunosorbent assay (ELISA)
testing, IgM ELISA, polymerase chain reaction (PCR) and
virus isolation can be used to diagnose a case of EHF
within a few days of the onset of symptoms. Persons
tested later in the course of the disease or after recovery
can be tested for IgM and IgG antibodies; the disease can
also be diagnosed retrospectively in deceased patients by
using immunohistochemistry testing, virus isolation, or
PCR [17].
Treatment: There is no standard treatment for EHF.
Patients receive supportive therapy. This consists of
balancing the patient’s fluids and electrolytes,
maintaining their oxygen status and blood pressure and
treating them for any complicating infections [17].
Treatment is symptomatic predominantly to preserve
hemostasis and to control the hemorrhagic diathesis and
shock. Fresh blood transfusions are recommended to
control the hemorrhagic diathesis under African
World J. Med. Sci., 11 (3): 324-333, 2014
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conditions. Exchange transfusion should be strictly 425 cases with 53% deaths. The outbreak in 2003 was first
avoided. It has not yet been proven that hemodialysis is recognized by a large number of dead gorillas and
beneficial. Treatment with serum from recovered patients chimpanzees. It was caused by the Zaire subtype; of 143
or Equine hyper-immune serum is recommended but has human cases, 89% were fatal [30].
not yet been thoroughly tested. Experimentally, On February 27, 2001, Uganda was declared officially
Filoviruses are susceptible to ribavirin and interferon. to be free of Ebola hemorrhagic fever, following a 42-day
Replication of  Filoviruses  in  cell culture can be inhibited period, twice the maximum incubation period, during
by lysosomotropic agents’ chloroquine and quinine [15]. which no new cases had been reported. According to the
Prevention and Control: Prevention measures should be deaths, from Ebola hemorrhagic fever (EHF) have been
directed above all toward avoiding inter-human reported from Yambio County in southern Sudan. On
transmission. It is necessary to isolate the patient and August 28, 2007, CDC was notified of cases of an
take immediate steps to institute strict containment unidentified disease in a remote area of Kasai Occidental
nursing practices. In addition, all samples taken for Province in the Democratic Republic of Congo (DRC). The
diagnostic purposes, excreta and any other materials that onset of the latest laboratory-confirmed case was on
may have been in contact with the patient should be September 29, 2007. On October 1, 2007, the total of
regarded as infectious and handled and decontaminated suspected cases was 249 with 183 deaths. On November
using the appropriate procedures [28]. 26, 2007, CDC received blood samples from the Ugandan
To prevent the spread of infection to their partners, Ministry of Health, taken from 20 of the 49 patients
males should not engage in sexual intercourse until three involved in an outbreak of an unknown illness in
months after clinical recovery, or until semen is shown to Bundibugyo district in western Uganda. Patients reported
be free of the virus [17]. The number of health workers fever, enteritis and bleeding. Of the 49, 14 have died.
assigned to the patients care should be restricted and all Genetic sequencing of a small segment of viral RNA from
such individuals should be dually trained and provided samples indicated the presence of a previously unknown
with complete protective gear, including gowns, gloves, strain of Ebola virus. At the invitation of the Ugandan
masks, goggles, caps and overshoes [29]. Deceased Ministry of Health, CDC, WHO, MSF and other
victims should be promptly cremated or buried, preferably collaborators deployed field investigators to the affected
in a plastic bag by persons wearing protective clothing region; additionally, a laboratory was set up in Entebbe at
[14]. the Uganda Virus Research Institute (UVRI). As the
The prevention of EHF in Africa presents many outbreak neared conclusion in January 2008, the total
challenges. Because the identity and location of the number of suspected cases was 149, with 37 deaths. On
natural reservoir of Ebola virus are unknown, there are few May 14, 2011, the Ugandan Ministry of Health informed
established primary prevention measures [17]. the public that a patient with suspected Ebola
Current Status in Africa: In 1967, 31 cases of district, Uganda. CDC-Uganda confirmed a positive Ebola
Hemorrhagic fever with seven deaths, occurred among virus test result from a blood sample taken from the
laboratory workers in Germany and Yugoslavia who were patient. The quick diagnosis of Ebola virus was provided
processing kidneys from African green monkeys by the new CDC Viral Hemorrhagic Fever laboratory
(Cercopithecus aethiops) that had been imported from installed at the Uganda Viral Research Institute (UVRI)
Uganda [3]. [31].
In 1976, two severe epidemics of hemorrhagic fever On July 28, 2012, the Uganda Ministry of Health
occurred in Sudan and Zaire. The virus responsible was reported an outbreak of Ebola Hemorrhagic Fever in the
named Ebola virus after a river in Zaire. The outbreaks Kibaale District of Uganda. A total of 24 human cases
involved more than 500 cases and at least 400 deaths due (probable and confirmed only), 17 of which were fatal,
to clinical hemorrhagic fever. Another epidemic occurred were reported starting at the beginning of July.
in Kikwit, Zaire in 1995. There were at least 315 identified Laboratory tests of blood samples, conducted by the
cases with 80% mortality. The causative agent was the Uganda Virus Research Institute (UVRI) and the U.S.
Zaire sub-type of Ebola virus. Outbreaks of EHF occurred Centers for Disease Control and Prevention (CDC),
in Uganda in 2000 and the DRC in 2003. The Ugandan confirmed Ebola virus in 11 patients, four of whom died.
epidemic was caused by the Sudan subtype; there were Reported numbers are subject to change [28-30].
World Health Organization (WHO), 20 cases, including 5
Hemorrhagic fever died on May 6, 2011 in the Luwero
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On October 4, 2012, the Uganda Ministry of Health concern for development as bioterrorism agents make the
declared the outbreak ended. The DRC Ministry of Health disease an economically important emerging disease
has declared an end to the most recent Ebola outbreak in being the hot issue for mass medias and different
DRC's Province Orientale. The November 26 Press Release organizations.
reports a final total of 77 cases, including 36 laboratory-
confirmed cases, 17 probable and 24 suspect cases, with Based on the above conclusion the following
a total of 36 deaths. As of December 2, 2012, the Ugandan recommendations are forwarded:
Ministry of Health reported 7 cumulative cases (probable
and confirmed) of Ebola virus infection, including 4 Awareness should be created about the disease to
deaths, in the Luwero District of central Uganda [30-31]. prevent its spread. 
According to the World Health Organization (WHO), As the disease has no effective treatment
the Ministry of Health (MoH) of Guinea reported 236 prevention and control measures based on further
probable and suspect cases, including 158 deaths on investigations should be implemented to mitigate
April 10, 2014. Of these suspect cases, 66 have been the disease.
laboratory confirmed positive cases of Ebola hemorrhagic Those that are at high risk like health professionals
fever (EHF). One additional health care worker with should take appropriate care when handling
clinical symptoms has been reported since April 7, patients.
increasing the total to 15 health care workers. All cases Hunters, laboratory workers and those having
reported in Conakry (20) have been laboratory confirmed. contact with primates or secretions should also be
Other districts with confirmed and suspected cases remain protected when handling animals and specimens.
Guekedou, Macenta, Kissidougou, Dabola and Dead persons and animals should be buried
Djingaraye. UNICEF of Liberia reported on April 9, 2014, appropriately to avoid potential source of infection.
22 probable and suspect cases of EHF, including 14 As the disease is the current issue worldwide,
deaths and 5 laboratory-confirmed cases. Four of these thorough studies on the disease like on vaccine
confirmed cases were reported from Lofa County and 1 development should be done.
from Margibi County according to WHO. Other Counties Men infected with Ebola virus should not have sex
in  Liberia  under  further  investigation  now include for 3 months or until tests Show that semen is free
Bong, Nimba,  Montserrado  and  for  the  first  time, of the virus.
Grand Cape Mount County. Additional reports of suspect As the disease is not reported in Ethiopia
cases in Sierra Leone and Mali are under investigation appropriate measures should be taken to the
[31]. movement of animals and people from abroad.
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